LLNL inventors developed a proprietary desorption technology that enabled separation of a near-adjacent panel of REEs, marking the best separation...
Life Sciences, Biotech, and Healthcare
Life science instrumentation, medical diagnostics, bioengineering, and methods for rare earth element (REE) extraction and purification enable a variety of applications including imaging and forensics, rapid PCR, biosensors, brain computer interface, bioprinting and enhanced delivery of therapeutics to support national health security along with a U.S. supply chain for REEs needed in various industries.
People
Capabilities
Healthcare
- Diagnostics, therapeutics and prophylactics
- Computational design or redesign of proteins and small molecules for therapeutic or prophylactic applications
Biothreat
- BSL-3 facility for the study of known and emerging biological threats and pandemics
- Medical countermeasures
- Biodetection and biosurveillance
Life Science Instrumentation
- Microbes-inspired extraction and separation of rare earth elements (REEs)
Brain-Computer Interface (BCI)
- Implantable neural devices
- A dedicated medical device foundry uniquely positioned to build devices through advanced prototyping and into human clinical studies
Bioprinting and Biomanufacturing
Facilities
Explore Technologies
Maximizing rare earth element separation with Lanmodulin protein using a novel desorption technology
Genetic engineering allows insertion and propagation of a foreign genetic element in a heterologous system in a variety of applications such as the...
LLNL researchers have developed an approach to form silicon carbide (and diamond) nanoneedles using plasma etching that create micro pillars followed...
After screening at least 50 different cyclodextrins, LLNL researchers found that the drug Subetadex shows enhanced affinities for fentanyl and its...
Rather than using genes carried by viruses, LLNL researchers have developed an alternative approach of delivering CAR to T-cells in form of proteins...
LLNL inventors have developed a method and device for the high throughput screening of various chemical and biological entities using a novel...
LLNL inventors have developed a proprietary concept and a prototype NVU device that provides an effective in vitro model of the BBB to discover...
LLNL researchers have designed and developed a novel high-density, high-channel count 3D connector that enables hundreds or thousands of nonpermanent...
As an important step toward overcoming the technical and environmental limitations of current REE processing methods, the LLNL team has patented and...
LLNL researchers have enhanced and expanded the IDEA technology, which fabricates micron-scale droplets that are then crosslinked in-air (within...
LLNL researchers have discovered that some inexpensive and commercially available molecules used for other applications, could render certain...
To address shortcomings of current liposome drug delivery systems, the patented innovation uses drug-loaded liposomes containing carbon nanotube...
A new approach of developing synthetic antibacterial mineral assemblages can be used as an alternative treatment when traditional antibiotics fail in...
The method described in a pending patent application uses a novel thiacrown (dibenzohexathia-18-crown-6) for efficient extraction of 197m,gHg and...
Combining the principles of nanotechnology, cell-free protein synthesis and microfluidics, LLNL researchers have developed a reusable, portable...
Many of the disadvantages of current interface devices can be overcome with LLNL’s novel interface design, which relies on area array distribution...
To replicate the physiology and functionality of tissues and organs, LLNL has developed an in vitro device that contains 3D MEAs made from flexible...
High throughput discovery of linear B-cell epitopes for the development of vaccines and therapeutics
LLNL’s high throughput method involves proteome-wide screening for linear B-cell epitopes using native proteomes isolated from a pathogen of interest...
Commercial fiber optic cables are the current standard for carrying optical signals in industries like communications or medical devices. However, the...
Solid-state distributed node-based rapid thermal cycler for extremely fast nucleic acid amplification (LLNL Internal Case # IL-12275, US Patent 8,720...
Laser heating of aqueous samples on a micro-optical-electro-mechanical system (LLNL Internal Case # IL-11719, US Patents 8,367,976 ; 8,610,032 )...
LLNL researchers have designed a synthetic, concatemeric bacterial expression vector that expresses a protein sequence that can be digested into a...
LLNL scientists have created a technology that utilizes electrical means, instead of optical methods, to (1) provide label-free detection of droplet...
This device allows for observation of single cells encapsulated in droplets and provide the ability to recover droplets containing a cell of interest...
This invention consists of a functionalized membrane (e.g. polyethylene glycol (PEG)) and osmosis or electric potential as a driving force. The PEG...
This invention is an improved chromatography device that utilizes the concept of a functionally graded material (FGM) for separation of components...
The art described here incorporates a planar integrated optical system that allows for multiple biochemical assays to be run at the same time or...
This technology describes a method for partitioning fluid into “packets” between polymeric sheets. The fluid to be partitioned is introduced between...
LLNL researchers have developed a variation of AMS technology that improves sample preparation, analysis, and cost for AMS. The device involves...
LLNL has invented a new high-throughput assay for sample separation that uses the vibrations of a piezoelectric transducer to produce acoustic...
LLNL researchers have developed an apparatus capable of measuring and recording ultraviolet radiation that uses the Schottky diode/ZnSe/metal type UV...
The invention developed by LLNL researchers proposes to use staged isotachophoresis to improve sample separation. One of the problems with...
LLNL researchers have devolved a technique to separate or purify samples using electrophoretic separation. This invention corrects the problem...
Researchers at LLNL have developed a more efficient and cost-effective method and system for synthesizing a critical D-aminoluciferin precursor and...
LLNL's technology employs improved sorting strategies related to chip-based droplet sorting. This technology uses electromagnetic fields and non...
Researchers at LLNL have developed a method to passively sort individual microdroplet samples of uniform size based on stiffness and viscosity. Unlike...
LLNL researchers have created a method that uses isotachophoresis for the exclusion and or purification of nucleic acids. Isotachopheresis (ITP) is an...
The steady-state phenomenon generates thousands of microdroplets per second which is a problem when the stream of droplets needs to be slowed down or...
The present invention uses magnetic fields to hold particles in place for faster DNA amplification and sequencing. This invention provides a method...
This invention is designed to sort and identify complex samples using parallel nucleic acid characterization. By isolating single or double stranded...
This technology is a photonic detection system developed by researchers at LLNL for the detection of biological or chemical threats with the intention...
The described invention is a miniature fluidic device for separating particles suspended within a liquid sample that is introduced into the interior...
Researchers at LLNL have developed a nanotube sensor (single-walled or multi-walled carbon nanotubes) enclosed within a highly selective lipid bilayer...
Researchers at LLNL have created a new technology for performing pumping and valving operations in microfabricated fluidic systems. Traditional...
Researchers at LLNL have developed a new method to utilize highly selective molecular recognition events to attach proteins to any solid support...
LLNL has a successful history of developing instruments for detecting and characterizing airborne pathogens. Often, aerosol characterizing instruments...
LLNL scientists have designed a rapid PCR technology that incorporates the use of microfluidic thermal heat exchanger systems and is comprised of a...
LLNL has developed a new technology that provides a method for near-instantaneous heating of aqueous samples in microfluidic devices. The technology...
Researchers at LLNL have developed an instantaneous sample heating method to efficiently deposit thermal energy into a continuous stream or segmented...
Researchers at LLNL have designed a new technology that allows the integration of a large bench-top thermal cycling instrument onto a miniaturized...
LLNL researchers have developed a high-volume, low-cost diagnostic test that is easy to use and provides results in under an hour. The testing...
This technology describes a method for performing immediate in-line sample heating to promote the required chemical reactions for amplification...
LLNL researchers have developed a new method for faster, more accurate, and precise thermal control for DNA amplification. This technology uses sensor...
LLNL scientists developed novel hydrogels, which are biodegradable soft materials synthesized by a water-soluble polymer. Incorporating silver imparts...
LLNL researchers have developed a method to quickly and accurately identify the family of a virus infecting a vertebrate via PCR. Universal primer...
LLNL scientists have developed a high-confidence, real-time multiplexed reverse transcriptase PCR (RT-PCR) rule-out assay for foot and mouth disease...
LLNL scientists have developed a method to ensure the accuracy of that tomographic image by applying adaptive optics (AO) to OCT in a single...
LLNL researchers have developed a portable device which analyzes one or multiple types of body fluids or gases to test for one or more medical...
LLNL researchers have invented a system for identifying all known and unknown pathogenic or non-pathogenic organisms in a sample. This invention takes...
This LLNL-developed invention is multiplexed and utilizes the Luminex bead-based liquid array, which contains 100 different unique beads...
LNLL scientists have invented a method for multiplexed detection of PCR amplified products which can be completed in a single step. Highly validated...
LLNL scientists have developed a battery-powered device which is low-cost and multi-chambered for the extraction and amplification of nucleic acids...
LLNL has developed a brain-on-a-chip system with a removable cell-seeding funnel to simultaneously localize neurons from various brain regions in an...
Lawrence Livermore National Laboratory scientists have developed a signal enhancing microchip apparatus and method that enhances a microfluidic...
Using various excitation wavelengths, a hyperspectral microscope takes advantage of autofluorescence and polarized light scattering from cellular...
LLNL has developed a novel process of production, isolation, characterization, and functional re-constitution of membrane-associated proteins in a...
LLNL’s BioBriefcase is a compact and portable instrument capable of autonomously detecting the full spectrum of bioagents, including bacteria, viruses...
The biotech industry aims to move towards an on-chip system for sample generation, amplification and detection of both DNA and RNA based organisms...
LLNL has developed a technology that provides near-instantaneous heating of aqueous samples in microfluidic devices. The method heats samples in a...
This technology uses either of two X-ray wave-front sensor techniques, Hartmann sensing and two-dimensional shear interferometry, both of which are...
Stories
LLNL researchers, partnerships office earn technology transfer awards
LLNL researchers and IPO win Federal Laboratory Consortium (FLC) 2026 Excellence in Tech Transfer Award for commercializing the Laboratory’s Lanmodulin-Based Rare Earth Purification (LanPure) with Alta Resource Technologies.
Annual LLNL tech transfer report highlights how partnerships advance technologies to market
In FY24, LLNL reported 201 total copyrights, filed 134 U.S. patents and recorded 119 new invention disclosures — illustrating the Laboratory’s pipeline of cutting-edge technologies, available for partnership, stemming from its mission-based research.
Lawrence Livermore National Laboratory leads groundbreaking DeNOVO initiative in AI antibody design
In a pioneering project aimed at revolutionizing the design of antibodies and antibody-like molecules through the power of AI, Lawrence Livermore National Laboratory (LLNL) is working to transform medical countermeasure development and biologics discovery.
Cancer drug candidate developed using supercomputing & AI blocks tumor growth without toxic side effect
A new cancer drug candidate developed by Lawrence Livermore National Laboratory (LLNL), BBOT (BridgeBio Oncology Therapeutics) and the Frederick National Laboratory for Cancer Research (FN
Inspired by nature, proteins pick out mission-critical metals
Rare-earth elements are essential for many electronic, energy and advanced defense technologies.
LLNL and Canaery develop cutting-edge neural interface technology for scent detection
LLNL and neurotechnology company Canaery have developed an advanced nose-computer interface (NCI) capable of enhancing the ability of scent-detection animals to simultaneously identify contraband such as explosives and narcotics, as well as other types of im
LLNL and BioVind achieve diagnostics milestone
Technology designed to aid on-the-field diagnostics for military applications is gaining a wider reach as Lawrence Livermore National Laboratory (LLNL) and BioVind, LLC achieved a milestone in their partnership: the exclus
Innovation and Partnerships Office employee wins second national award
Following a Federal Laboratory Consortium (FLC) award win in April, Lawrence Livermore National Lab (LLNL) has received its second national recognition for
LLNL and BridgeBio announce trials for supercomputing-discovered cancer drug
In a substantial milestone for supercomputing-aided drug design, Lawrence Livermore National Laboratory (LLNL) and BridgeBio Oncology Therapeutics (BridgeBio) today announced clinical trials have begun for a first-in-class m
A-Alpha Awarded Additional $14.5M from the DOD to Accelerate Antibody Discovery and Optimization for Likely Biothreats
Funding from the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) will expand A-Alpha's partnership with Lawrence Livermore National Laboratory (LLNL) in support of the Generative Unconstrained Intelligent Drug Engineering (GUIDE) program.
GUIDE team develops approach to redesign antibodies against viral pandemics
In a groundbreaking development for addressing future viral pandemics, a multi-institutional team involving Lawrence Livermore National Laboratory (LLNL) researchers has successfully combined an artificial intelligence (AI)-backed platform with supercomputing to re
LLNL researcher, business development executive capture technology transfer award from consortium
A Lawrence Livermore National Laboratory (LLNL) researcher and a colleague who helped him and his team commercialize their biomedical technology have garnered a national technology transfer award.
LLNL and Precision Neuroscience collaboration aims to develop next-generation neural implants
Lawrence Livermore National Laboratory (LLNL) has joined forces with Precision Neuroscience Corporation (Precision) to advance the technology of neural implants for patients suffering from a variety of neurological disor
Synthetic antibacterial minerals combat topical infections
The development of new antibiotics has stalled — new strategies are needed as the world enters the age of antibiotic resistance. To combat this challenge, Lawrence Livermore National Laboratory (LLNL) scientists have found that synthetic an
BridgeBio announces FDA clearance of IND application for BBO-8520
BBO-8520’s discovery was the result of a collaboration between the RAS Initiative FNL, Lawrence Livermore National Laboratory, and BridgeBio.
Lab scientists and engineers garner three awards for top inventions in R&D 100 competition
Lawrence Livermore National Laboratory (LLNL) scientists and engineers have netted three awards among the top 100 inventions worldwide. The trade journal R&D Worl
New film captures LLNL engineer-turned-astronaut’s inspiring journey
José Hernández’s life story can now be found on the small screen with the new film “A Million Miles Away”. Of note in the article, Hernández stated he is “most proud of is the fact that the Lab embraced the digital mammography project, the work Clint Logan, Laura Mascio and I did, allowed u
Mixed for the Perfect Match article in JSTO's in the News (Vol 12, No. 8)
Harmful biological pathogens, such as viruses, bacteria, fungi, protozoa, and worms, continue to pose a threat to the Joint Force. To combat these natural challenges and better defend warfighters from bioterrorism and biowarfare, the DTRA's Chemical and Biological Technologies Department in
LLNL biomedical licensee collaborating with two drug companies to advance treatments for autoimmune diseases
In late 2017, LLNL licensed a biomedical technology called nanolipoprotein particles (NLPs), which can deliver vaccines and drugs inside the cells in the human body, to Ann Arbor, Michigan-based EVOQ Therapeutics.
Shape Memory Medical Receives FDA Clearance for the IMPEDE® FX Embolization Plug
LLNL licensee, Shape Memory Medical Inc., announced it has received 510(k) clearance from the US FDA for its IMPEDE-FX Embolization Plug. The IMPEDE product family features a proprietary Shape Memory Polymer (SMP) initially developed at LLNL.
Art with a purpose: LLNL and startup company imagine the future of indoor carbon capture
LLNL is collaborating with Artveoli to develop technology which can capture CO2 from building interiors. This device would be so versatile that it could be inconspicuously placed in a room as a piece of wall art.
LLNL's LLMDA technology licensed to ThermoFisher wins a National FLC Excellence in Technology Transfer award
We congratulate our technologists and private sector partner for winning this prestigious technology transfer award.
Bio businesses booming: Life science companies (small and large) thriving in Pleasanton
IPO supports regional economic development and is proud of the incredible reach LLNL technology has in bolstering the Tri-Valley economy.
Lawrence Livermore and three employees win 'best in class' national tech transfer award
Recognition by your peers is a satisfying reward. Building and supporting the ATOM consortium has been a big success for IPO. Congratulations Candice, Charity and Quentin!
SafeTraces raises $10M in equity financing
Congratulations to LLNL licensee, SafeTraces, for closing a financing round to continue efforts to bring LLNL's technology to market providing a food traceability solution for agricultural producers.
Shape Memory Medical Receives FDA Clearance for the IMPEDE® Embolization Plug
LLNL licensee Shape Memory Medical hits a major milestone in road to commercialization.
SafeTraces Raises $6.5m Series A for Traceability Tech Led By Omidyar
LLNL licensee, SafeTraces, has hit a major fundraising milestone in their journey to commercialize lab technology, DNATrax.
Lawrence Livermore Microbial Detection Array (LLMDA) detects viruses in human clinical samples
The Livermore team, in collaboration with Statens Serum Institut in Denmark, have demonstrated the potential and real life utility of the microarray technique for broad-spectrum pathogen detection in clinical samples. Their results are published in the online journal PLoS ONE.
Lawrence Livermore National Laboratory | 7000 East Avenue, Livermore, CA 94550 | LLNL-WEB-2020415. Operated by the Lawrence Livermore National Security, LLC for the Department of Energy’s National Nuclear Security Administration. Learn about the Department of Energy’s Vulnerability Disclosure Program.
Lawrence Livermore National Laboratory | 7000 East Avenue, Livermore, CA 94550 | LLNL-WEB-2020415. Operated by the Lawrence Livermore National Security, LLC for the Department of Energy’s National Nuclear Security Administration. Learn about the Department of Energy’s Vulnerability Disclosure Program.